Breast response to menopausal hormone therapy—aspects on proliferation, apoptosis and mammographic density
Author:
- 1 January 2007
- journal article
- review article
- Published by Taylor & Francis in Annals of Medicine
- Vol. 39 (1) , 28-41
Abstract
Breast cancer is the major malignancy among women in the Western world. The breast is clearly a target organ for sex steroid hormones and hormonal treatments have been associated with an increased risk of breast cancer. The balance between proliferation and apoptosis is important for breast cell homeostasis. Mammographic breast density has been identified as a strong and independent risk factor for breast cancer. It seems clear that there is a difference between various hormonal treatments with regard to their effects on breast density and cell proliferation. Also, not all women respond similarly to the same treatment. Combined estrogen and progestogen therapy generally will enhance density and proliferation more than treatment with estrogen alone. Certain constitutional and hormonal factors appear to be predictive of breast reactivity. Older women with a low body mass index respond more strongly to treatment. Estrogen levels have a positive and androgens a negative association to increase in density and proliferation. A combination of increased proliferation and decreased apoptosis could be one mechanism to explain the excess risk of breast cancer during combined estrogen/progestogen treatment. Tibolone seems to have less impact on breast response than conventional hormone therapy. Efforts should be made to identify those women with an adverse response to treatment as well as therapeutic principles with the least possible influence on the breast.Keywords
This publication has 104 references indexed in Scilit:
- Estrogen Carcinogenesis in Breast CancerNew England Journal of Medicine, 2006
- Hormone receptor status in breast cancer – a comparison between surgical specimens and fine needle aspiration biopsiesCytopathology, 2003
- Circulating concentrations of insulin-like growth factor I and risk of breast cancerThe Lancet, 1998
- Steroid hormones and cancer: (II) lessons from experimental systemEuropean Journal of Surgical Oncology, 1997
- Cloning of a novel receptor expressed in rat prostate and ovary.Proceedings of the National Academy of Sciences, 1996
- Breast cancer screening with mammography: overview of Swedish randomised trialsThe Lancet, 1993
- ApoptosisImmunology Today, 1993
- Plasma insulin-like growth factor-1 (IGF-1) concentrations in human breast cancerEuropean Journal of Cancer, 1993
- Apoptosis and the regulation of cell numbers in normal and neoplastic tissues: an overviewCancer and Metastasis Reviews, 1992
- Immunophenotypic Difference of Keratin Expression in Normal Mammary Glandular Cells from Five Different SpeciesCells Tissues Organs, 1991